The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma.

Gakis, Georgios; Schubert, Tina; Morgan, Todd M; Daneshmand, Siamak; Keegan, Kirk A; Mischinger, Johannes; Clayman, Rebecca H; Brisuda, Antonin; Ali-El-Dein, Bedeir; Galland, Sigolene; Gregg, Justin; Balci, Melih; Olugbade, Kola; Rink, Michael; Fritsche, Hans-Martin; Burger, Maximilian; Babjuk, Marko; Stenzl, Arnulf; Thalmann, George; Kübler, Hubert; ... (2018). The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urologic oncology - seminars and original investigations, 36(1), 10.e7-10.e14. Elsevier 10.1016/j.urolonc.2017.09.012

[img] Text
Tha_UrolOncol_The procnostic effect of salvage_2018.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (309kB) | Request a copy

BACKGROUND

To evaluate the impact of salvage therapy (ST) on overall survival (OS) in recurrent primary urethral cancer (PUC).

PATIENTS

A series of 139 patients (96 men, 43 women; median age = 66, interquartile range: 57-77) were diagnosed with PUC at 10 referral centers between 1993 and 2012. The modality of ST of recurrence (salvage surgery vs. radiotherapy) was recorded. Kaplan-Meier analysis with log-rank was used to estimate the impact of ST on OS (median follow-up = 21, interquartile range: 5-48).

RESULTS

The 3-year OS for patients free of any recurrence (I), with solitary or concomitant urethral recurrence (II), and nonurethral recurrence (III) was 86.5%, 74.5%, and 48.2%, respectively (P = 0.002 for I vs. III and II vs. III; P = 0.55 for I vs. II). In the 80 patients with recurrences, the modality of primary treatment of recurrence was salvage surgery in 30 (37.5%), salvage radiotherapy (RT) in 8 (10.0%), and salvage surgery plus RT in 5 (6.3%) whereas 37 patients did not receive ST for recurrence (46.3%). In patients with recurrences, those who underwent salvage surgery or RT-based ST had similar 3-year OS (84.9%, 71.6%) compared to patients without recurrence (86.7%, P = 0.65), and exhibited superior 3-year OS compared to patients who did not undergo ST (38.0%, P<0.001 compared to surgery, P = 0.045 to RT-based ST, P = 0.29 for surgery vs. RT-based ST).

CONCLUSIONS

In this study, patients who underwent ST for recurrent PUC demonstrated improved OS compared to those who did not receive ST and exhibited similar survival to those who never developed recurrence after primary treatment.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Thalmann, George

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1078-1439

Publisher:

Elsevier

Language:

English

Submitter:

Laetitia Hayoz

Date Deposited:

03 Jul 2018 11:58

Last Modified:

22 Oct 2019 21:20

Publisher DOI:

10.1016/j.urolonc.2017.09.012

PubMed ID:

29055518

Uncontrolled Keywords:

Primary urethral carcinoma Radiotherapy Recurrence Salvage Surgery

BORIS DOI:

10.7892/boris.118234

URI:

https://boris.unibe.ch/id/eprint/118234

Actions (login required)

Edit item Edit item
Provide Feedback